Navigation Links
Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
Date:12/3/2007

a, Switzerland, where he oversaw the global launch of Rebif(R), the leading therapy for Multiple Sclerosis. In addition, Ronen was the Regional Product Manager for Neurology and Metabolism for Serono's Intercontinental Business Operations.

Ronen holds a degree in Biology from Bar-Ilan University in Israel and an MBA from Warwick Business School in the UK.

About microRNAs

MicroRNAs (miRNAs) are recently discovered, naturally occurring small RNAs that act as master regulators and have the potential to form the basis for a new class of diagnostics and therapeutics. Since many diseases are caused by the abnormal activity of proteins, the ability to selectively regulate protein activity through microRNAs could provide the means to treat a wide range of human diseases. In addition, microRNAs have been shown to have different expression levels in certain diseased versus normal tissues. As a result, these differences potentially provide for a novel diagnostic strategy for many diseases. MicroRNAs are thought to play a key role in the differentiation of cells into specific cell types performing various functions in the body.

About Rosetta Genomics

Rosetta Genomics (Nasdaq: ROSG) is a leader in the development of microRNA-based diagnostics and therapeutics. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and strategic alliances with leading biotechnology companies, Rosetta Genomics is working to develop a full range of diagnostic and therapeutic products based on microRNAs. The company's primary focus i
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
3. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
4. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
5. NeoGenomics Announces Results for the 3rd Quarter 2007
6. Kenyan malaria success strengthens call for free insecticide-treated nets for all
7. International study strengthens case for daily calcium pill
8. Wachovia Strengthens Its Healthcare Industry Receivables and Cash Management Capabilities
9. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
10. Publicis Groupe Strengthens its Leadership in Digital and Integrated Healthcare Communications in Italy
11. NIAID strengthens and expands Vaccine and Treatment Evaluation Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 27, 2015 “ Nursing Homes are starting ... reads the title of a recent April 2015 New York ... loved ones to the hospital, 20-plus years of research have ... shows that high-quality nursing homes are both safer for older ... quality of nursing homes varying widely, patients and family members ...
(Date:5/27/2015)... May 27, 2015 While hair transplantation ... loss, a new pilot study conducted by a physician ... (ISHRS) has found hair follicle grafting can help treat ... was partially funded by ISHRS, which offers research grants ... hair restoration. , In the past decade, numerous ...
(Date:5/27/2015)... TX (PRWEB) May 27, 2015 The ... information. Topics include: Why investors should consider oil and ... how and why wells are drilled, industry news, IRA ... Carson Energy's 32 years of knowledge and experience is ... gas investment community to be able to access 24 ...
(Date:5/27/2015)... NJ (PRWEB) May 27, 2015 ... Network (BCAN) , whose mission is to advance research, ... cancer, have joined forces to battle the fifth most ... in the bladder’s lining start to grow out of ... and their families at every stage of the cancer ...
(Date:5/27/2015)... Difass USA, a modern supplement brand committed ... first three flagship products, Dormiva™, Relaxiva™ and Reminiva™. All ... http://www.difassusa.com . , A restful night’s sleep is ... people struggle with getting the full amount of sleep ... designed to help you fall asleep and stay asleep, ...
Breaking Medicine News(10 mins):Health News:BestNursingHomes.com Launches on National Senior Health and Fitness Day 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 3Health News:Carson Energy Launches Next Generation Investor Website 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 3Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2
... (Amex: HH ) today announced the appointment ... Counsel and Corporate Secretary. He has also been ... has over 23 years of corporate legal experience in ... consumer and other class actions, as well as labor, ...
... Jan. 27 Mercury Computer Systems, Inc. (NASDAQ: ... computing systems and software for complex image, sensor, and ... agreement and closed on the sale of its wholly-owned ... GmbH, to Australia-based Pro Medicus Limited. The financial terms ...
... researchers say , , TUESDAY, Jan. 27 (HealthDay News) -- ... potential new method of promoting recovery from chronic stress ... "fight or flight" response. , The approach focuses on ... body,s major control systems. The HPA axis uses hormone ...
... following was released today by the Healthcare Information and ... and Management Systems Society (HIMSS) will join the U.S. ... a press conference to call attention to the widespread ... Recovery and Reinvestment Plan of 2009 currently pending in ...
... FLA) Leading medical experts at the Center for ... School of Medicine (BUSM) reported today that nine-year NFL ... from chronic traumatic encephalopathy (CTE), a degenerative brain disease ... at the age of 45. In addition, the CSTE ...
... ValueOptions(R), Inc., the nation,s largest independent ... North Carolina Employer Solutions Service Center received a ... Quality Assurance (NCQA), an independent, not-for-profit organization dedicated ... managed care plans, managed behavioral health care organizations ...
Cached Medicine News:Health News:Hooper Holmes Names Mark Rosenblum Senior Vice President, General Counsel and Corporate Secretary 2Health News:Hooper Holmes Names Mark Rosenblum Senior Vice President, General Counsel and Corporate Secretary 3Health News:Mercury Computer Systems Announces the Sale of Visage Imaging to Pro Medicus Limited 2Health News:Mercury Computer Systems Announces the Sale of Visage Imaging to Pro Medicus Limited 3Health News:Mercury Computer Systems Announces the Sale of Visage Imaging to Pro Medicus Limited 4Health News:Center for the Study of Traumatic Encephalopathy announces new findings 2Health News:Center for the Study of Traumatic Encephalopathy announces new findings 3Health News:Center for the Study of Traumatic Encephalopathy announces new findings 4Health News:Center for the Study of Traumatic Encephalopathy announces new findings 5Health News:NCQA Awards Accredited Status to ValueOptions(R) North Carolina Employer Solutions Service Center 2Health News:NCQA Awards Accredited Status to ValueOptions(R) North Carolina Employer Solutions Service Center 3
(Date:5/27/2015)... NEW YORK , May 27, 2015  Precision ... announced the findings from its 2015 Digital Trends Study ... decision makers are aware of the concepts of big ... fully implement them.  The Health Information ... incentives for healthcare providers to make use of electronic ...
(Date:5/27/2015)... , May 27, 2015 ... addition of the  "North America Portable X Ray ... - 2019)"  report to their offering.  ... North America market for Portable X-Ray ... CAGR from 2014 to 2020 X-Ray ...
(Date:5/27/2015)... , May 27, 2015  With all the ... the services they provide to keep patients healthy should ... ripple effect of the Affordable Care Act continues to ... insurance payer partners, making it more important than ever ... communication with those they contract with for patient care. ...
Breaking Medicine Technology:Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 2Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 3North America Portable X Ray Devices Market Report 2015 - Growth, Trends And Forecasts 2014-2019 2Physicians Seek Payer Inclusion, Not Impediment 2Physicians Seek Payer Inclusion, Not Impediment 3
... Boehringer Ingelheim and Eli Lilly and Company ... positive opinion from the European Medicines Agency,s (EMA) medicinal ... (to be marketed under the trade name Trajenta® in ... diabetes. If adopted by the European Commission, linagliptin will ...
... Md., June 24, 2011 Breast cancer patients and their ... am outside of the Federal Drug Administration (FDA).  At issue ... drug Avastin from the approved medication list for treatment of ... 2008 for use to treat breast cancer. Terry ...
Cached Medicine Technology:Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe 2Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe 3Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe 4Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe 5Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe 6Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe 7Breast Cancer Patients and Families Stand Up To FDA 2
... 10% Povidone Iodine USP, 1% available Iodine, ... prep, Povidone Iodine Gel helps to minimize ... patient, thus reducing the chance of patient ... a one step gel for venipuncture site ...
... is a viscous antimicrobial that contains 10% ... broad-spectrum germicidal action. As a preoperative patient ... the pooling of prepping solutions under the ... burns. Povidone Iodine Topical Gel is film ...
... is appropriate for pre-surgical patient preparation ... spray); disinfecting of wounds and burns; ... and abrasions. It also acts as ... and office procedures, providing protection against ...
Idophor PVP Scrub Winged Sponges...
Medicine Products: